Page last updated: 2024-08-21

thiazoles and dihydropyridines

thiazoles has been researched along with dihydropyridines in 60 studies

Research

Studies (60)

TimeframeStudies, this research(%)All Research%
pre-19907 (11.67)18.7374
1990's24 (40.00)18.2507
2000's19 (31.67)29.6817
2010's10 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, E; Jacobs, A; Peter, H; Wong, A1
Alonso, S; Artalejo, CR; Cillero, J; Fau de Casa-Juana, M; García, AG; González-Morales, MA; López, MG; Santos, L; Sunkel, CE; Villarroya, M1
Hancock, WW; Kupiec-Weglinski, JW; Tilney, NL; Whitley, D1
Cook, EP; Fragonas, JC; Hunt, NH1
Bergeron, RJ; Dionis, JB; Egli-Karmakka, M; Frei, J; Huxley-Tencer, A; Peter, HH; Wiegand, J1
Bergeron, RJ; Evans, KM; Jenny, HB; Luchetta, G; Peter, H; Streiff, RR; Vinson, JR; Wiegand, J1
Bierer, BE; Nathan, DG1
Wolfe, LC1
Chaudhri, G; Clark, IA1
Finger, J; Hegsted, M; Nathan, DG; Nicolosi, RJ; Peter, H; Renaud, MM; Wolfe, LC1
Baquet, A; Crichton, RR; Florence, A; Jin, Y; Schneider, YJ1
Cochrane, CG; Hyslop, PA; Jackson, JH; Sauerheber, R; Schraufstatter, IU; Vosbeck, K; Weitzman, SA1
Hiller, W; Maichle, C; Schechinger, T; Strähle, J; Weser, U1
Beaudoin, RL; Gentilini, M; Guillouzo, A; Landau, I; Langlois, P; Mazier, D; Mellouk, S; Miltgen, F; Stahel, E1
Crichton, RR; Longueville, A1
Artalejo, CR; Cillero, FJ; de Casa-Juana, MF; de Pascual, R; García, AG; González-Morales, MA; López, MG; Priego, J; Sunkel, C; Villarroya, M1
Artalejo, AR; de la Fuente, MT; del Valle, M; Gandía, L; García, AG; Montiel, C; Vinet, R1
Bergeron, RJ; Wiegand, J; Wollenweber, M1
Algee, SE; Bergeron, RJ; Liu, CZ; McManis, JS; Wiegand, J; Xia, MX1
DeSousa, M; Hancock, WW; Kupiec-Weglinski, JW; Tilney, NL; Whitley, WD1
Bergeron, RJ; Creary, EA; Daniels, RD; King, W; Luchetta, G; Moerker, T; Peter, HH; Streiff, RR; Wiegand, J1
Algee, SE; Bergeron, RJ; McManis, JS; Ratliff-Thompson, K; Wiegand, J; Wollenweber, M1
Nakagawa, M; Sasaki, S1
Gandía, L; García, AG; Lara, B; Martínez-Sierra, R; Torres, A1
Adachi, Y; Fukazawa, M; Kato, T; Suzuki, Y; Tamura, K1
Diéguez, G; Fernández, N; García, AG; García, JL; López, MG1
Bergeron, RJ; Ratliff-Thompson, K; Weimar, WR; Wiegand, J1
Horga, JF; Javaloy, J; Román, JF; Vidal, MT; Zapater, P1
Crichton, RR; Dexter, DT; Florence, A; Jenner, P; Ward, RJ1
Bergeron, RJ; Brittenham, GM; Bussenius, J; McManis, JS; Wiegand, J1
Bergeron, RJ; Weimar, WR; Wiegand, J1
Baker, E; Chua, AC; Kicic, A1
Bergeron, RJ; Huang, G; McManis, JS; Smith, RE; Weimar, WR; Wiegand, J1
Bergeron, RJ; Huang, G; McManis, JS; Weimar, WR; Wiegand, J1
Bergeron, RJ; Nguyen, JN; Sninsky, CA; Weimar, WR; Wiegand, J1
Acklin, P; Alberti, D; Buehlmayer, P; Hauffe, S; Lattmann, R; Nick, H; Schupp, J1
Abboud, KA; Bergeron, RJ; McManis, JS; Smith, RE; Weimar, WR; Wiegand, J1
Bergeron, J; Bergeron, RJ; Brittenham, GM; Eiler-McManis, E; McManis, JS; Park, JH; Weimar, WR; Wiegand, J1
Bihel, F; Garino, C; Kraus, JL; Laras, Y; Pietrancosta, N; Quéléver, G; Sheha, M; Wolfe, MS1
Hu, X; Lu, Q; Qiangrong, P; Wang, T1
Hider, RC; Zhou, T1
Bergeron, RJ; Bharti, N; McManis, JS; Wiegand, J3
Bergeron, RJ; Bharti, N; Rocca, JR; Singh, S; Wiegand, J1
Bélanger, C; Borgeat, P; Elimam, H; Lefebvre, J; Marleau, S1
Andreani, A; Bedini, A; Budriesi, R; Chiarini, A; Cosconati, S; Di Toro, R; Ioan, P; Leoni, A; Locatelli, A; Marinelli, L; Novellino, E; Spampinato, S; Ugenti, MP1
Bergeron, RJ; Bharti, N; McManis, JS; Singh, S; Wiegand, J3
Fan, HW; Hu, Q; Ji, HJ; Xiao, DW; Zhou, XH; Zhu, YB; Zou, JJ1
Bergeron, RJ; Singh, S; Wiegand, J1
Kim, SH; Kim, YJ; Koh, SH; Lee, KY; Lee, YJ; Park, HH; Park, KH1
Abboud, KA; Bergeron, RJ; Bharti, N; McManis, JS; Singh, S; Wiegand, J1
Al-Qasoumi, SI; Al-Said, MS; Bashandy, MS; Ghorab, MM1
Jójártné, LO; Mártha, C; Szabóné, RP1
Bedini, A; Budriesi, R; Chiarini, A; Cosconati, S; Ioan, P; Leoni, A; Locatelli, A; Marinelli, L; Micucci, M; Novellino, E; Spampinato, SM1
Fadda, AA; Refat, HM1
Aydinok, Y; Berk, G; Cohen, AR; Giardina, PJ; Jeglinski, BI; Kuo, KH; Kwiatkowski, JL; Neufeld, EJ; Pietropaolo, K; Saliba, AN; Taher, AT; Viprakasit, V1
Dev, A; Jayaprakash, V; Shyam, M; Sinha, BN1

Reviews

5 review(s) available for thiazoles and dihydropyridines

ArticleYear
[Calcium channel blocker for therapy of patients with hypertension].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:8

    Topics: Benzimidazoles; Calcium Channel Blockers; Dihydropyridines; Drug Interactions; Humans; Hypertension; Mibefradil; Nifedipine; Tetrahydronaphthalenes; Thiazoles

1997
Structure-activity relationships among desazadesferrithiocin analogues.
    Advances in experimental medicine and biology, 2002, Volume: 509

    Topics: Animals; Dihydropyridines; Drug Design; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Siderophores; Structure-Activity Relationship; Thiazoles

2002
Development of tridentate iron chelators: from desferrithiocin to ICL670.
    Current medicinal chemistry, 2003, Volume: 10, Issue:12

    Topics: Animals; Benzoates; Callithrix; Chemical Phenomena; Chemistry, Physical; Deferasirox; Dihydropyridines; Dogs; Humans; Iron; Iron Chelating Agents; Rats; Thiazoles; Triazoles

2003
Desferrithiocin: a search for clinically effective iron chelators.
    Journal of medicinal chemistry, 2014, Nov-26, Volume: 57, Issue:22

    Topics: Animals; Chemistry, Pharmaceutical; Dihydropyridines; Drug Design; Electron Transport; Ferritins; Homeostasis; Humans; Iron; Iron Chelating Agents; Iron Overload; Ligands; Oxidation-Reduction; Primates; Rats; Rats, Sprague-Dawley; Siderophores; Structure-Activity Relationship; Thiazoles; Transferrin

2014
Scaffold Based Search on the Desferithiocin Archetype.
    Mini reviews in medicinal chemistry, 2019, Volume: 19, Issue:19

    Topics: Benzene Derivatives; Dihydropyridines; Humans; Iron Chelating Agents; Iron Overload; Pyridines; Structure-Activity Relationship; Thiazoles

2019

Trials

2 trial(s) available for thiazoles and dihydropyridines

ArticleYear
Determination of azelnidipine by LC-ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteers.
    Die Pharmazie, 2008, Volume: 63, Issue:8

    Topics: Adult; Antipsychotic Agents; Azetidinecarboxylic Acid; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Dihydropyridines; Female; Humans; Isoindoles; Male; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Thiazoles

2008
Safety and pharmacokinetics of the oral iron chelator SP-420 in β-thalassemia.
    American journal of hematology, 2017, Volume: 92, Issue:12

    Topics: Adolescent; Adult; beta-Thalassemia; Blood Transfusion; Cyclohexanones; Dihydropyridines; Dose-Response Relationship, Drug; Humans; Iron Chelating Agents; Kidney Diseases; Middle Aged; Siderophores; Thiazoles; Young Adult

2017

Other Studies

53 other study(ies) available for thiazoles and dihydropyridines

ArticleYear
Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic.
    British journal of haematology, 1992, Volume: 81, Issue:3

    Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Cells, Cultured; Deferoxamine; Dihydropyridines; Dose-Response Relationship, Drug; Injections, Subcutaneous; Iodine Radioisotopes; Iron; Iron Chelating Agents; Iron Radioisotopes; Liver; Rats; Rats, Wistar; Thiazoles; Time Factors; Transferrin; Weight Gain

1992
Synthesis of 3-[(2,3-dihydro-1,1,3-trioxo-1,2-benzisothiazol-2-yl)alkyl] 1,4-dihydropyridine-3,5-dicarboxylate derivatives as calcium channel modulators.
    Journal of medicinal chemistry, 1992, Jun-26, Volume: 35, Issue:13

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Cations; Dihydropyridines; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Potassium; Rabbits; Rats; Rats, Inbred Strains; Thiazoles

1992
Oral iron chelator desferrithiocin blocks allogeneic mononuclear cell activation and cytokine production in vivo and prolongs rat cardiac allograft survival.
    Transplantation proceedings, 1992, Volume: 24, Issue:1

    Topics: Animals; Cytokines; Dihydropyridines; Graft Survival; Heart Transplantation; Iron Chelating Agents; Lymphocyte Activation; Macrophage Activation; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Receptors, Interleukin-2; T-Lymphocytes; Thiazoles; Transplantation, Homologous

1992
Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytes.
    International journal of immunopharmacology, 1991, Volume: 13, Issue:7

    Topics: Animals; B-Lymphocytes; Deferoxamine; Dihydropyridines; DNA; Ferricyanides; Humans; In Vitro Techniques; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxygen; T-Lymphocytes; Thiazoles

1991
Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:7

    Topics: Administration, Oral; Animals; Bile; Chemical Phenomena; Chemistry; Dihydropyridines; Drug Evaluation, Preclinical; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Thiazoles

1991
A comparative evaluation of iron clearance models.
    Annals of the New York Academy of Sciences, 1990, Volume: 612

    Topics: Animals; Bile; Chelating Agents; Deferoxamine; Dihydropyridines; Haplorhini; Hydrazines; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Spectrophotometry, Atomic; Thiazoles

1990
The effect of desferrithiocin, an oral iron chelator, on T-cell function.
    Blood, 1990, Nov-15, Volume: 76, Issue:10

    Topics: Antigens, Surface; Calcium; Cell Division; Cell Membrane; Cells, Cultured; Cytotoxicity, Immunologic; Deferoxamine; Dihydropyridines; Humans; Interleukin-2; Iron; Iron Chelating Agents; Killer Cells, Natural; Lymphocyte Activation; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Thiazoles

1990
Desferrithiocin.
    Seminars in hematology, 1990, Volume: 27, Issue:2

    Topics: Animals; Dihydropyridines; Iron Chelating Agents; Thiazoles

1990
Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor.
    Journal of immunology (Baltimore, Md. : 1950), 1989, Aug-15, Volume: 143, Issue:4

    Topics: Animals; Antioxidants; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Deferoxamine; Dihydropyridines; Free Radicals; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred CBA; Oxygen; Peritoneal Cavity; Thiazoles; Tumor Necrosis Factor-alpha

1989
A non-human primate model for the study of oral iron chelators.
    British journal of haematology, 1989, Volume: 72, Issue:3

    Topics: Administration, Oral; Animals; Cebus; Deferoxamine; Dihydropyridines; Disease Models, Animal; Injections, Intramuscular; Iron; Iron Chelating Agents; Thiazoles

1989
Desferrithiocin and desferrioxamine B. Cellular pharmacology and storage iron mobilization.
    Biochemical pharmacology, 1989, Oct-01, Volume: 38, Issue:19

    Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Iron; Liver; Male; Rats; Rats, Inbred Strains; Thiazoles; Tritium

1989
Role of oxidants in DNA damage. Hydroxyl radical mediates the synergistic DNA damaging effects of asbestos and cigarette smoke.
    The Journal of clinical investigation, 1987, Volume: 80, Issue:4

    Topics: Asbestos; Bacteriophages; Benzoates; Benzoic Acid; Catalase; Dihydropyridines; Dimethyl Sulfoxide; DNA; Drug Synergism; Electron Spin Resonance Spectroscopy; Hydroxides; Hydroxyl Radical; Mannitol; Nucleic Acid Conformation; Phenanthrolines; Smoking; Superoxide Dismutase; Thiazoles

1987
A five-coordinate copper complex with superoxide dismutase mimetic activity from Streptomyces antibioticus.
    Biology of metals, 1988, Volume: 1, Issue:2

    Topics: Circular Dichroism; Copper; Dihydropyridines; Electron Spin Resonance Spectroscopy; Iron Chelating Agents; Models, Molecular; Spectrophotometry; Streptomyces; Streptomyces antibioticus; Superoxide Dismutase; Thermodynamics; Thiazoles; X-Ray Diffraction

1988
Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
    The American journal of tropical medicine and hygiene, 1988, Volume: 39, Issue:3

    Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Humans; Iron Chelating Agents; Liver; Malaria; Microscopy, Electron; Plasmodium falciparum; Plasmodium yoelii; Rats; Thiazoles

1988
An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.
    Biochemical pharmacology, 1986, Nov-01, Volume: 35, Issue:21

    Topics: Administration, Oral; Animals; Body Weight; Chelating Agents; Deferoxamine; Dihydropyridines; Ferritins; Ferrous Compounds; Injections, Intraperitoneal; Liver; Male; Metallocenes; Organ Size; Organometallic Compounds; Pyridines; Rats; Rats, Inbred Strains; Thiazoles

1986
PCA 50941, a novel Ca2+ channel agonist.
    European journal of pharmacology, 1993, Oct-12, Volume: 243, Issue:1

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta; Calcium Channel Agonists; Cardiovascular System; Dihydropyridines; Heart Atria; In Vitro Techniques; Isradipine; Mesenteric Arteries; Muscles; Nitrendipine; Rabbits; Rats; Rats, Sprague-Dawley; Swine; Thiazoles; Vasoconstriction

1993
Interactions between Ca2+, PCA50941 and Bay K 8644 in bovine chromaffin cells.
    European journal of pharmacology, 1994, Aug-16, Volume: 268, Issue:3

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenal Medulla; Animals; Calcium; Calcium Channel Agonists; Calcium Channels; Catecholamines; Cattle; Cell Membrane; Cytosol; Dihydropyridines; Fura-2; In Vitro Techniques; Isradipine; Patch-Clamp Techniques; Potassium; Thiazoles

1994
An investigation of desferrithiocin metabolism.
    Journal of medicinal chemistry, 1994, Sep-02, Volume: 37, Issue:18

    Topics: Animals; Chromatography, High Pressure Liquid; Cysteine; Dihydropyridines; Female; Hydrolysis; Iron; Kinetics; Male; Mice; Rats; Rats, Sprague-Dawley; Siderophores; Thiazoles

1994
The desferrithiocin pharmacophore.
    Journal of medicinal chemistry, 1994, May-13, Volume: 37, Issue:10

    Topics: Animals; Dihydropyridines; Drug Design; Iron; Iron Chelating Agents; Male; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles

1994
Iron chelation suppresses mononuclear cell activation, modifies lymphocyte migration patterns, and prolongs rat cardiac allograft survival in rats.
    Transplantation, 1993, Volume: 56, Issue:5

    Topics: Animals; Cell Movement; Dihydropyridines; Graft Survival; Heart Transplantation; Iron; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Rats; Rats, Inbred BN; Rats, Inbred Lew; Siderophores; T-Lymphocyte Subsets; Thiazoles; Transplantation, Homologous; Tumor Necrosis Factor-alpha

1993
A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model.
    Blood, 1993, Apr-15, Volume: 81, Issue:8

    Topics: Animals; Cebus; Deferoxamine; Dihydropyridines; Feces; Gastrointestinal Diseases; Iron; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Siderophores; Thiazoles

1993
Synthesis and biological evaluation of naphthyldesferrithiocin iron chelators.
    Journal of medicinal chemistry, 1996, Apr-12, Volume: 39, Issue:8

    Topics: Animals; Cebus; Dihydropyridines; Iron; Iron Chelating Agents; Male; Rats; Rats, Sprague-Dawley; Thiazoles

1996
Q-type Ca2+ channels are located closer to secretory sites than L-type channels: functional evidence in chromaffin cells.
    Pflugers Archiv : European journal of physiology, 1998, Volume: 435, Issue:4

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Catecholamines; Cattle; Chromaffin Cells; Dihydropyridines; In Vitro Techniques; Neurosecretory Systems; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptides; Piperidines; Potassium; Spider Venoms; Thiazoles

1998
CP-060S interacts with three principal binding sites on the L-type Ca2+ channel.
    European journal of pharmacology, 1998, Jan-26, Volume: 342, Issue:2-3

    Topics: Animals; Binding, Competitive; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Heart; In Vitro Techniques; Kinetics; Male; Myocardium; Radioligand Assay; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidines

1998
PCA50941, a new 1,4-dihydropyridine, reverses endothelin-induced cardiogenic shock in the anesthetized goat.
    Life sciences, 1998, Volume: 62, Issue:21

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Flow Velocity; Blood Pressure; Calcium Channel Agonists; Coronary Circulation; Dihydropyridines; Endothelin-1; Female; Goats; Heart; Heart Rate; Infusions, Intravenous; Shock, Cardiogenic; Thiazoles; Ventricular Function, Left

1998
The origin of the differences in (R)- and (S)-desmethyldesferrithiocin. Iron-clearing properties.
    Annals of the New York Academy of Sciences, 1998, Jun-30, Volume: 850

    Topics: Animals; Cebus; D-Amino-Acid Oxidase; Deferoxamine; Dihydropyridines; Iron; Iron Chelating Agents; Kinetics; Male; Metabolic Clearance Rate; Molecular Structure; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles

1998
Anticonvulsant effects of nimodipine and two novel dihydropyridines (PCA 50922 and PCA 50941) against seizures elicited by pentylenetetrazole and electroconvulsive shock in mice.
    Brain research, 1998, Jun-15, Volume: 796, Issue:1-2

    Topics: Animals; Anticonvulsants; Calcium Channel Agonists; Calcium Channel Blockers; Clonazepam; Dihydropyridines; Electroshock; Female; Male; Mice; Mice, Inbred Strains; Nimodipine; Pentylenetetrazole; Phenytoin; Seizures; Thiazoles

1998
Effects of desferrithiocin and its derivatives on peripheral iron and striatal dopamine and 5-hydroxytryptamine metabolism in the ferrocene-loaded rat.
    Biochemical pharmacology, 1999, Jul-01, Volume: 58, Issue:1

    Topics: Administration, Oral; Animals; Corpus Striatum; Dihydropyridines; Dopamine; Ferrous Compounds; In Vitro Techniques; Iron; Iron Chelating Agents; Iron Overload; Male; Metallocenes; Rats; Rats, Wistar; Serotonin; Thiazoles

1999
Evaluation of the desferrithiocin pharmacophore as a vector for hydroxamates.
    Journal of medicinal chemistry, 1999, Jul-29, Volume: 42, Issue:15

    Topics: Administration, Oral; Animals; Cebus; Dihydropyridines; Drug Evaluation, Preclinical; Hydroxamic Acids; Injections, Subcutaneous; Iron Chelating Agents; Iron Overload; Ligands; Male; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles

1999
Pharmacokinetics of orally administered desferrithiocin analogs in cebus apella primates.
    Drug metabolism and disposition: the biological fate of chemicals, 1999, Volume: 27, Issue:12

    Topics: Administration, Oral; Animals; Cebus; Dihydropyridines; Humans; Iron Chelating Agents; Serum Albumin; Thiazoles

1999
Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.
    British journal of pharmacology, 2002, Volume: 135, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Deferoxamine; Dihydropyridines; Fibroblasts; Hepatocytes; Humans; Iron; Iron Chelating Agents; Male; Mice; Rats; Rats, Wistar; Thiazoles; Tumor Cells, Cultured

2002
Desferrithiocin analogue based hexacoordinate iron(III) chelators.
    Journal of medicinal chemistry, 2003, Jan-02, Volume: 46, Issue:1

    Topics: Animals; Ascorbic Acid; Bile; Cebus; Dihydropyridines; Feces; Free Radical Scavengers; Iron; Iron Chelating Agents; Ligands; Oxidation-Reduction; Resorcinols; Structure-Activity Relationship; Thiazoles

2003
Prevention of acetic acid-induced colitis by desferrithiocin analogs in a rat model.
    Digestive diseases and sciences, 2003, Volume: 48, Issue:2

    Topics: Acetic Acid; Animals; Colitis; Dihydropyridines; Disease Models, Animal; Drug Interactions; Intestinal Mucosa; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Sensitivity and Specificity; Thiazoles

2003
Iron chelation promoted by desazadesferrithiocin analogs: An enantioselective barrier.
    Chirality, 2003, Volume: 15, Issue:7

    Topics: Animals; Cebus; Crystallography, X-Ray; Dihydropyridines; Feces; Humans; Iron Chelating Agents; Mice; Stereoisomerism; Thiazoles

2003
Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance.
    Journal of medicinal chemistry, 2005, Feb-10, Volume: 48, Issue:3

    Topics: Animals; Antioxidants; Ascorbic Acid; Catechols; Cebus; Dihydropyridines; Free Radical Scavengers; Humans; In Vitro Techniques; Iron; Iron Chelating Agents; Liver; Male; Myocardium; Oxidation-Reduction; Pancreas; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles; Tissue Distribution

2005
Substituted thiazolamide coupled to a redox delivery system: a new gamma-secretase inhibitor with enhanced pharmacokinetic profile.
    Organic & biomolecular chemistry, 2005, Feb-21, Volume: 3, Issue:4

    Topics: Alzheimer Disease; Amides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Biological Availability; Blood-Brain Barrier; Dihydropyridines; Drug Delivery Systems; Endopeptidases; Enzyme Inhibitors; Humans; Male; Molecular Structure; Nicotinic Acids; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Thiazoles

2005
Schisandrin B--a novel inhibitor of P-glycoprotein.
    Biochemical and biophysical research communications, 2005, Sep-23, Volume: 335, Issue:2

    Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Cell Line, Tumor; Cell Proliferation; Cyclooctanes; Daunorubicin; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Humans; Inhibitory Concentration 50; K562 Cells; Lignans; Models, Chemical; Neoplasms; Polycyclic Compounds; Protein Binding; Tetrazolium Salts; Thiazoles; Time Factors

2005
The design of orally active iron chelators.
    Annals of the New York Academy of Sciences, 2005, Volume: 1054

    Topics: Administration, Oral; Benzoates; Clinical Trials as Topic; Deferasirox; Dihydropyridines; Drug Design; Drug Evaluation, Preclinical; Humans; Iron; Iron Chelating Agents; Ligands; Models, Molecular; Molecular Structure; Oxidation-Reduction; Pyridones; Thiazoles; Triazoles

2005
The design, synthesis, and evaluation of organ-specific iron chelators.
    Journal of medicinal chemistry, 2006, Nov-30, Volume: 49, Issue:24

    Topics: Animals; Bile; Carboxylic Acids; Cebus; Dihydropyridines; Iron Chelating Agents; Iron-Dextran Complex; Kidney; Liver; Male; Myocardium; Organ Specificity; Pancreas; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Tissue Distribution

2006
Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution.
    Journal of medicinal chemistry, 2007, Jul-12, Volume: 50, Issue:14

    Topics: Animals; Cebus; Dihydropyridines; Iron; Iron Chelating Agents; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Rats; Rats, Sprague-Dawley; Species Specificity; Thiazoles; Tissue Distribution

2007
Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.
    Immunology, 2008, Volume: 124, Issue:3

    Topics: Animals; Benzopyrans; Carboxylic Acids; Dermatitis; Dihydropyridines; Imidazoles; Leukotriene B4; Male; Neutrophil Infiltration; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pneumonia; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Leukotriene B4; Skin; Thiazoles

2008
Imidazo[2,1-b]thiazole system: a scaffold endowing dihydropyridines with selective cardiodepressant activity.
    Journal of medicinal chemistry, 2008, Mar-27, Volume: 51, Issue:6

    Topics: Animals; Binding Sites; Computer Simulation; Dihydropyridines; Drug Design; Drug Evaluation, Preclinical; Guinea Pigs; Heart; Heart Rate; Imidazoles; Ligands; Models, Molecular; Molecular Structure; Muscle, Smooth, Vascular; Myocardial Contraction; Myocytes, Cardiac; Small Molecule Libraries; Structure-Activity Relationship; Thiazoles

2008
Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues.
    Journal of medicinal chemistry, 2008, Jul-10, Volume: 51, Issue:13

    Topics: Animals; Biliary Tract; Cercopithecus; Dihydropyridines; Drug Design; Ether; Iron; Iron Chelating Agents; Kidney; Kinetics; Male; Molecular Structure; Rats; Structure-Activity Relationship; Thiazoles

2008
Desferrithiocin analogues and nephrotoxicity.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Administration, Oral; Animals; Cebus; Dihydropyridines; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Iron; Iron Chelating Agents; Iron Overload; Kidney Diseases; Ligands; Lipids; Male; Molecular Conformation; Rats; Rats, Sprague-Dawley; Stereoisomerism; Thiazoles; Water

2008
Desferrithiocin analogue uranium decorporation agents.
    International journal of radiation biology, 2009, Volume: 85, Issue:4

    Topics: Animals; Bile Ducts; Chelating Agents; Dihydropyridines; Dose-Response Relationship, Drug; Femur; Kidney; Ligands; Liver; Lung; Pentetic Acid; Rats; Spleen; Thiazoles; Uranium

2009
Cilnidipine mediates a neuroprotective effect by scavenging free radicals and activating the phosphatidylinositol 3-kinase pathway.
    Journal of neurochemistry, 2009, Volume: 111, Issue:1

    Topics: Analysis of Variance; Animals; Apoptosis; Calcium Channel Blockers; Cell Differentiation; Cell Survival; Dihydropyridines; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Free Radical Scavengers; Hydrogen Peroxide; Indoles; Neurons; omega-Conotoxins; Oxidants; Oxidative Stress; PC12 Cells; Phosphatidylinositol 3-Kinases; Rats; Signal Transduction; Tetrazolium Salts; Thiazoles

2009
The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues.
    Journal of medicinal chemistry, 2010, Apr-08, Volume: 53, Issue:7

    Topics: Animals; Bile Ducts; Cebus; Chemical Phenomena; Crystallography, X-Ray; Dihydropyridines; Drug Design; Ether; Ethers; Humans; Iron; Iron Chelating Agents; Iron Overload; Kidney; Ligands; Male; Octanols; Rats; Thiazoles; Water

2010
Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Dihydropyridines; Humans; Inhibitory Concentration 50; Structure-Activity Relationship; Thiazoles; Thiophenes

2011
Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity.
    Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2011, Volume: 24, Issue:2

    Topics: Animals; Cebus; Cell Adhesion Molecules; Dihydropyridines; Feces; Iron; Iron Chelating Agents; Kidney; Male; Molecular Structure; Rats; Rats, Sprague-Dawley; Thiazoles

2011
[Amorphous form in pharmaceutical technological research].
    Acta pharmaceutica Hungarica, 2011, Volume: 81, Issue:1

    Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chlorhexidine; Clopidogrel; Dihydropyridines; Gemfibrozil; Glass; Ibuprofen; Loratadine; Meloxicam; Pharmaceutical Preparations; Piroxicam; Sorbitol; Technology, Pharmaceutical; Thiazines; Thiazoles; Ticlopidine

2011
Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.
    Journal of medicinal chemistry, 2012, Aug-23, Volume: 55, Issue:16

    Topics: Administration, Oral; Animals; Cebus; Coordination Complexes; Dihydropyridines; Ethers; Ferric Compounds; Hydroxylation; Iron Chelating Agents; Iron Overload; Kidney; Ligands; Male; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles

2012
Ligand based approach to L-type calcium channel by imidazo[2,1-b]thiazole-1,4-dihydropyridines: from heart activity to brain affinity.
    Journal of medicinal chemistry, 2013, May-23, Volume: 56, Issue:10

    Topics: Animals; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cerebral Cortex; Computer Simulation; Dihydropyridines; Guinea Pigs; Heart; Heart Rate; Imidazoles; In Vitro Techniques; Models, Molecular; Muscle, Smooth; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Rats; Structure-Activity Relationship; Thiazoles

2013
Synthesis and antimicrobial activity of some novel hydrazide, benzochromenone, dihydropyridine, pyrrole, thiazole and thiophene derivatives.
    European journal of medicinal chemistry, 2013, Volume: 70

    Topics: Anti-Bacterial Agents; Antifungal Agents; Benzopyrans; Candida albicans; Dihydropyridines; Dose-Response Relationship, Drug; Escherichia coli; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Pyrroles; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Thiophenes

2013